CLX

Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Total revenue 1.43 B1.67 B1.67 B— — Gross profit 596 M722 M722 M— — Operating expenses 305 M291 M256 M28 M 880 M Selling/general/admin expenses 277 M262 M229 M— — Research & development 28 M29 M27 M— — Operating income 291 M431 M466 M-28 M 1.16 B Non-Operating Income, Total 10 M4 M-1 M0 13 M Interest expense, net of interest capitalized 23 M25 M27 M— — Non-Operating Income, excl. Interest Expenses -13 M-21 M-28 M0 -62 M Unusual income/expense ———— — Pretax income 107 M215 M256 M791 M 1.37 B Equity in earnings 1 M1 M0— — Taxes 25 M54 M65 M206 M 350 M Non-controlling/minority interest 2 M4 M4 M— — After tax other income/expense 12 M4 M2 M— — Net income before discontinued operations 80 M157 M187 M585 M 1.01 B Discontinued operations ———— — Net income 80 M157 M187 M585 M 1.01 B Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 80 M157 M187 M585 M 1.01 B Basic earnings per share (Basic EPS) 0.651.291.54— — Diluted earnings per share (Diluted EPS) 0.651.291.544.79 8.27 Average basic shares outstanding 122.63 M121.6 M121.36 M121.78 M — Diluted shares outstanding 123.02 M121.92 M121.79 M122.13 M — EBITDA 347 M486 M524 M— — EBIT 291 M431 M466 M— — Cost of revenue 833 M951 M948 M— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) 56 M55 M58 M28 M 197 M